Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: JEOL USA, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-01-01 to 2023-12-31
Current total value of award: $208607.4
Description: PER THE 711 NDAA, USAMRAA HAS TRANSITIONED TO THE DHA EFFECTIVE 10/1/2022. EXERCISE OPTION PERIOD WITH FULL FUNDING.